Risk factors for hypoglycaemia in neurocritical care patients
详细信息 查看全文
- 作者：Freya M. van Iersel (1)
Arjen J. C. Slooter (1)
Renee Vroegop (1)
Annemiek E. Wolters (1)
Charlotte A. M. Tiemessen (1)
Rik H. J. R?sken (1)
Johannes G. van der Hoeven (2)
Linda M. Peelen (3)
Cornelia W. E. Hoedemaekers (2) - 关键词：Hypoglycaemia ; Insulin ; Intensive care units ; Nervous system diseases ; Risk factors
- 刊名：Intensive Care Medicine
- 出版年：2012
- 出版时间：December 2012
- 年：2012
- 卷：38
- 期：12
- 页码：1999-2006
- 全文大小：196KB
- 参考文献：1. Van den Berghe G, Schoonheydt K, Becx P, Bruyninckx F, Wouters PJ (2005) Insulin therapy protects the central and peripheral nervous system of intensive care patients. Neurology 64:1348-353 class="external" href="http://dx.doi.org/10.1212/01.WNL.0000158442.08857.FC">CrossRef
2. Johnston KC, Hall CE, Kissela BM, Bleck TP, Conaway MR (2009) Glucose Regulation in Acute Stroke Patients (GRASP) trial: a randomized pilot trial. Stroke 40:3804-809 class="external" href="http://dx.doi.org/10.1161/STROKEAHA.109.561498">CrossRef
3. Bilotta F, Caramia R, Cernak I, Paoloni FP, Doronzio A, Cuzzone V, Santoro A, Rosa G (2008) Intensive insulin therapy after severe traumatic brain injury: a randomized clinical trial. Neurocrit Care 9:159-66 class="external" href="http://dx.doi.org/10.1007/s12028-008-9084-9">CrossRef
4. Bilotta F, Spinelli A, Giovannini F, Doronzio A, Delfini R, Rosa G (2007) The effect of intensive insulin therapy on infection rate, vasospasm, neurologic outcome, and mortality in neurointensive care unit after intracranial aneurysm clipping in patients with acute subarachnoid hemorrhage: a randomized prospective pilot trial. J Neurosurg Anesthesiol 19:156-60 class="external" href="http://dx.doi.org/10.1097/ANA.0b013e3180338e69">CrossRef
5. Bruno A, Kent TA, Coull BM, Shankar RR, Saha C, Becker KJ, Kissela BM, Williams LS (2008) Treatment of hyperglycemia in ischemic stroke (THIS): a randomized pilot trial. Stroke 39:384-89 class="external" href="http://dx.doi.org/10.1161/STROKEAHA.107.493544">CrossRef
6. Coester A, Neumann CR, Schmidt MI (2010) Intensive insulin therapy in severe traumatic brain injury: a randomized trial. J Trauma 68:904-11
7. Green DM, O’Phelan KH, Bassin SL, Chang CWJ, Stern TS, Asai SM (2010) Intensive versus conventional insulin therapy in critically ill neurologic patients. Neurocrit Care 13:299-06 class="external" href="http://dx.doi.org/10.1007/s12028-010-9417-3">CrossRef
8. Oksanen T, Skrifvars MB, Varpula T, Kuitunen A, Pettila V, Nurmi J, Castrén M (2007) Strict versus moderate glucose control after resuscitation from ventricular fibrillation. Intensive Care Med 33:2093-100 class="external" href="http://dx.doi.org/10.1007/s00134-007-0876-8">CrossRef
9. Thiele RH, Pouratian N, Zuo Z, Scalzo DC, Dobbs HA, Dumont AS, Kassell NF, Nemergut EC (2009) Strict glucose control does not affect mortality after aneurysmal subarachnoid hemorrhage. Anesthesiology 110:603-10 class="external" href="http://dx.doi.org/10.1097/ALN.0b013e318198006a">CrossRef
10. Antonelli M, Azoulay E, Bonten M, Chastre J, Citerio G, Conti G, De Backer D, Lemaire F, Gerlach H, Hedenstierna G, Joannidis M, Macrae D, Mancebo J, Maggiore SM, Mebazaa A, Preiser JC, Pugin J, Wernerman J, Zhang H (2010) Year in review in Intensive Care Medicine 2009: I. Pneumonia and infections, sepsis, outcome, acute renal failure and acid base, nutrition and glycaemic control. Intensive Care Med 36:196-09 class="external" href="http://dx.doi.org/10.1007/s00134-009-1742-7">CrossRef
11. Eslami S, Abu-Hanna A, de Keizer NF, Bosman RJ, Spronk PE, de Jonge E, Schultz MJ (2010) Implementing glucose control in intensive care: a multicenter trial using statistical process control. Intensive Care Med 36:1556-565 class="external" href="http://dx.doi.org/10.1007/s00134-010-1924-3">CrossRef
12. Brunkhorst FM, Engel C, Bloos F, Meier-Hellmann A, Ragaller M, Weiler N, Moerer O, Gruendling M, Oppert M, Grond S, Olthoff D, Jaschinski U, John S, Rossaint R, Welte T, Schaefer M, Kern P, Kuhnt E, Kiehntopf M, Hartog C, Natanson C, Loeffler M, Reinhart K, German Competence Network Sepsis (SepNet) (2008) Intensive insulin therapy and pentastarch resuscitation in severe sepsis. N Engl J Med 358:125-39 class="external" href="http://dx.doi.org/10.1056/NEJMoa070716">CrossRef
13. NICE-SUGAR Study Investigators, Finfer S, Chittock DR, Su SY, Blair D, Foster D, Dhingra V, Bellomo R, Cook D, Dodek P, Henderson WR, Hébert PC, Heritier S, Heyland DK, McArthur C, McDonald E, Mitchell I, Myburgh JA, Norton R, Potter J, Robinson BG, Ronco JJ (2009) Intensive versus conventional glucose control in critically ill patients. N Engl J Med 360:1283-297
14. Kreisel SH, Berschin UM, Hammes H-P, Leweling H, Bertsch T, Hennerici MG, Schwarz S (2009) Pragmatic management of hyperglycaemia in acute ischaemic stroke: safety and feasibility of intensive intravenous insulin treatment. Cerebrovasc Dis 27:167-75 class="external" href="http://dx.doi.org/10.1159/000185608">CrossRef
15. Mechanick JI, Handelsman Y, Bloomgarden ZT (2007) Hypoglycemia in the intensive care unit. Curr Opin Clin Nutr Metab Care 10:193-96 class="external" href="http://dx.doi.org/10.1097/MCO.0b013e32802b7016">CrossRef
16. Tiemessen CA, Hoedemaekers CW, van Iersel FM, R?sken GH, van der Hoeven J, Biessels GJ, Slooter AJ (2011) Intensive insulin therapy increases the risk of hypoglycemia in neurocritical care patients. J Neurosurg Anesthesiol 23:206-14 class="external" href="http://dx.doi.org/10.1097/ANA.0b013e31821aa6f2">CrossRef
17. Wiener RS, Wiener DC, Larson RJ (2008) Benefits and risks of tight glucose control in critically ill adults: a meta-analysis. JAMA 300:933-44 class="external" href="http://dx.doi.org/10.1001/jama.300.8.933">CrossRef
18. Shan L, Hao PP, Chen YG (2011) Efficacy and safety of intensive insulin therapy for critically ill neurologic patients: a meta-analysis. J Trauma 71:1460-464 class="external" href="http://dx.doi.org/10.1097/TA.0b013e3182250515">CrossRef
19. Oddo M, Schmidt JM, Carrera E, Badjatia N, Connolly ES, Presciutti M, Ostapkovich ND, Levine JM, Le Roux P, Mayer SA (2008) Impact of tight glycemic control on cerebral glucose metabolism after severe brain injury: a microdialysis study. Crit Care Med 36:3233-238 class="external" href="http://dx.doi.org/10.1097/CCM.0b013e31818f4026">CrossRef
20. Schlenk F, Nagel A, Graetz D, Sarrafzadeh AS (2008) Hyperglycemia and cerebral glucose in aneurysmal subarachnoid hemorrhage. Intensive Care Med 34:1200-207 class="external" href="http://dx.doi.org/10.1007/s00134-008-1044-5">CrossRef
21. Vespa P, Boonyaputthikul R, McArthur DL, Miller C, Etchepare M, Bergsneider M, Glenn T, Martin N, Hovda D (2006) Intensive insulin therapy reduces microdialysis glucose values without altering glucose utilization or improving the lactate/pyruvate ratio after traumatic brain injury. Crit Care Med 34:850-56 class="external" href="http://dx.doi.org/10.1097/01.CCM.0000201875.12245.6F">CrossRef
22. Naidech AM, Levasseur K, Liebling S, Garg RK, Shapiro M, Ault ML, Afifi S, Batjer HH (2010) Moderate hypoglycemia is associated with vasospasm, cerebral infarction, and 3-month disability after subarachnoid hemorrhage. Neurocrit Care 12:181-87 class="external" href="http://dx.doi.org/10.1007/s12028-009-9311-z">CrossRef
23. Schmutzhard E, Rabinstein AA (2011) Spontaneous subarachnoid hemorrhage and glucose management. Neurocrit Care 15:281-86 class="external" href="http://dx.doi.org/10.1007/s12028-011-9601-0">CrossRef
24. Arabi YM, Tamim HM, Rishu AH (2009) Hypoglycemia with intensive insulin therapy in critically ill patients: predisposing factors and association with mortality. Crit Care Med 37:2536-544 class="external" href="http://dx.doi.org/10.1097/CCM.0b013e3181a381ad">CrossRef
25. Krinsley JS, Grover A (2007) Severe hypoglycemia in critically ill patients: risk factors and outcomes. Crit Care Med 35:2262-267 class="external" href="http://dx.doi.org/10.1097/01.CCM.0000282073.98414.4B">CrossRef
26. Van den Berghe G, Wilmer A, Hermans G, Meersseman W, Wouters PJ, Milants I, Van Wijngaerden E, Bobbaers H, Bouillon R (2006) Intensive insulin therapy in the medical ICU. N Engl J Med 354:449-61 class="external" href="http://dx.doi.org/10.1056/NEJMoa052521">CrossRef
27. Vriesendorp TM, van Santen S, DeVries JH, de Jonge E, Rosendaal FR, Schultz MJ, Hoekstra JB (2006) Predisposing factors for hypoglycemia in the intensive care unit. Crit Care Med 34:96-01 class="external" href="http://dx.doi.org/10.1097/01.CCM.0000194536.89694.06">CrossRef
28. Knaus WA, Draper EA, Wagner DP, Zimmerman JE (1985) APACHE II: a severity of disease classification system. Crit Care Med 13:818-29 class="external" href="http://dx.doi.org/10.1097/00003246-198510000-00009">CrossRef
29. Robertshaw M, Lai KN, Swaminathan R (1989) Prediction of creatinine clearance from plasma creatinine: comparison of five formulae. Br J Clin Pharmacol 28:275-80 class="external" href="http://dx.doi.org/10.1111/j.1365-2125.1989.tb05427.x">CrossRef
30. Hermanides J, Vriesendorp TM, Bosman RJ, Zandstra DF, Hoekstra JB, Devries JH (2010) Glucose variability is associated with intensive care unit mortality. Crit Care Med 38:838-42 class="external" href="http://dx.doi.org/10.1097/CCM.0b013e3181cc4be9">CrossRef
31. Krinsley JS (2008) Glycemic variability: a strong independent predictor of mortality in critically ill patients. Crit Care Med 36:3008-013 class="external" href="http://dx.doi.org/10.1097/CCM.0b013e31818b38d2">CrossRef
32. Meyfroidt G, Keenan DM, Wang X, Wouters PJ, Veldhuis JD, Van den Berghe G (2010) Dynamic characteristics of blood glucose time series during the course of critical illness: effects of intensive insulin therapy and relative association with mortality. Crit Care Med 38:1021-029 class="external" href="http://dx.doi.org/10.1097/CCM.0b013e3181cf710e">CrossRef
33. van den Berghe G, Wouters P, Weekers F, Verwaest C, Bruyninckx F, Schetz M, Vlasselaers D, Ferdinande P, Lauwers P, Bouillon R (2001) Intensive insulin therapy in critically ill patients. N Engl J Med 345:1359-367 class="external" href="http://dx.doi.org/10.1056/NEJMoa011300">CrossRef
34. Schlenk F, Vajkoczy P, Sarrafzadeh A (2009) Inpatient hyperglycemia following aneurysmal subarachnoid hemorrhage: relation to cerebral metabolism and outcome. Neurocrit Care 11:56-3 class="external" href="http://dx.doi.org/10.1007/s12028-009-9222-z">CrossRef
35. Meierhans R, Béchir M, Ludwig S, Sommerfeld J, Brandi G, Haberthür C, Stocker R, Stover JF (2010) Brain metabolism is significantly impaired at blood glucose below 6?mM and brain glucose below 1?mM in patients with severe traumatic brain injury. Crit Care 14:R13 class="external" href="http://dx.doi.org/10.1186/cc8869">CrossRef
36. Su YY, Li X, Li SJ, Luo R, Ding JP, Wang L, Cao GH, Wang DY, Gao JX (2009) Predicting hospital mortality using APACHE II scores in neurocritically ill patients: a prospective study. J Neurol 256:1427-433 class="external" href="http://dx.doi.org/10.1007/s00415-009-5129-z">CrossRef
37. Hoedemaekers CWE, Klein Gunnewiek JMT, Prinsen MA, Willems JL, Van der Hoeven JG (2008) Accuracy of bedside glucose measurement from three glucometers in critically ill patients. Crit Care Med 36:3062-066 class="external" href="http://dx.doi.org/10.1097/CCM.0b013e318186ffe6">CrossRef - 作者单位：Freya M. van Iersel (1)
Arjen J. C. Slooter (1)
Renee Vroegop (1)
Annemiek E. Wolters (1)
Charlotte A. M. Tiemessen (1)
Rik H. J. R?sken (1)
Johannes G. van der Hoeven (2)
Linda M. Peelen (3)
Cornelia W. E. Hoedemaekers (2)
1. Department of Intensive Care Medicine, University Medical Center, P.O. Box 85500, Room F.06.149, 3508 GA, Utrecht, The Netherlands
2. Department of Intensive Care Medicine, Radboud University Medical Center, Nijmegen, The Netherlands
3. Julius Center for Health Sciences and Primary Care, University Medical Center, Utrecht, The Netherlands
文摘
Purpose To identify risk factors for hypoglycaemia in neurocritical care patients receiving intensive insulin therapy (IIT). Methods We performed a nested case–control study. All first episodes of hypoglycaemia (glucose <80?mg/dL, <4.4?mmol/L) in neurocritical care patients between 1 March 2006 and 31 December 2007 were identified. Patients were treated according to the local IIT protocol, with target blood glucose levels between 4.5 and 6.0?mmol/L (81.0-08.0?mg/dL). The first hypoglycaemic event of every patient (index moment) was used to match to a control patient. Possible risk factors preceding the index moment were scored using hospital records and analysed with conditional logistic regression. Results Of 786 neurocritical care patients, 449 developed hypoglycaemia (57.1?%). Independent risk factors for hypoglycaemia were lowering nutrition 6?h before the index moment without insulin dose reduction (odds ratio (OR) 5.25, 95?% confidence interval (95?% CI) 1.32-0.88), mechanical ventilation (OR 2.59, 95?% CI 1.56-.29), lowering the dosage of norepinephrine 3?h before the index moment (OR 2.44, 95?% CI 1.07-.55), a hyperglycaemic event (>10?mmol/L,?>180.0?mg/dL) in the 24?h preceding the index moment (OR 2.40, 95?% CI 1.26-.58), gastric residual in the 6?h preceding the index moment without insulin dose reduction (OR 1.76, 95?% CI 1.05-.96) and dosage of insulin at the index moment (OR 0.83, 95?% CI 0.76-.90). Conclusion Hypoglycaemia occurs in a considerable proportion of neurocritical care patients. We recommend the identification of these risk factors in these patients to avoid the occurrence of hypoglycaemia.